Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I I, Kokshenev"'
Publikováno v:
Pharmaceutical Chemistry Journal. 47:517-520
Hemantane is a novel antiparkinsonian drug that is undergoing clinical trials. Hemantane in the dosage range 10 – 40 mg/kg demonstrated anti-inflammatory activity and decreased statistically significantly the intensity of the exudative reaction in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::124c6ab0aaa4477262db610afdc7d29e
https://doi.org/10.1007/s11094-014-0994-x
https://doi.org/10.1007/s11094-014-0994-x
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 76(4)
A single intraperitoneal injection of MPTP neurotoxin (30 mg/kg) in C57BL/6 mice causes desynchronization of EEG with a decrease of theta-1 activity and a growth of beta activity in the interval of 15-30 Hz. Subchronic administration of the new antip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f2f23d4a8dc6ecddae55d3ffb3c307e
https://pubmed.ncbi.nlm.nih.gov/23762980
https://pubmed.ncbi.nlm.nih.gov/23762980
Autor:
Kapitsa, I. G.1 (AUTHOR), Ivanova, E. A.1 (AUTHOR) iwanowaea@yandex.ru, Avdyunina, N. I.1 (AUTHOR), Voronina, T. A.1 (AUTHOR)
Publikováno v:
Pharmaceutical Chemistry Journal. Aug2019, Vol. 53 Issue 5, p383-387. 5p.
Publikováno v:
Pharmaceutical Chemistry Journal. Jan2014, Vol. 47 Issue 10, p517-520. 4p.
Publikováno v:
Bulletin of Experimental Biology & Medicine; Jul2015, Vol. 159 Issue 3, p380-383, 4p
Publikováno v:
Journal of Physics: Conference Series; 2018, Vol. 1038 Issue 1, p1-1, 1p